AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

EARNZ PLC

Share Issue/Capital Change Sep 27, 2019

7609_rns_2019-09-27_ecf2e3c2-423d-4f3a-9fe0-b76ff293e74d.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9623N

Verditek PLC

27 September 2019

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

Verditek plc

Result of Placing

Verditek plc ("Verditek" or the "Company"), the internationally focussed clean technology company that primarily develops, produces and sells certified lightweight solar panels, with a current production capacity of 20 MW per annum, is pleased to announce that it has raised gross proceeds of £600,000 as a result of the Placing announced yesterday. Terms and expressions in this announcement will have the same meaning as in that announcement.

A total of 13,333,332 Placing Shares in the Company have been placed by WH Ireland with institutional and other investors at a price of 4.5 pence per Placing Share ("Issue Price"). A further 444,444 ordinary shares raising gross proceeds of £20,000 are expected to be issued, pursuant to a direct subscription, these subscription shares will be subject to a further application for admission to trading in due course.

In addition to the participation of Gavin Mayhew, a non-executive director, which has already been announced, Tim Lord, Chief Financial Officer, has now also subscribed for 139,444 new Ordinary Shares at the Placing Price in the Placing being an amount of £6,275. Under the AIM Rules, the Directors' participation in the Placing constitutes a related party transaction. Lord Willetts, who is not participating in the Placing, and so constitutes an independent Director for the purposes of the Placing considers, having consulted with WH Ireland, that the terms of the related party transaction are fair and reasonable insofar as the Shareholders are concerned.

The Issue Price represents a 26.8% premium to the closing price of Ordinary Shares on 25 September 2019 (being the last business day prior to the announcement of the Placing).

Application has been made for 13,333,332 Placing Shares to be admitted to trading on AIM ("Admission") and Admission is expected to occur on 1 October 2019. Following Admission of the Placing Shares, Verditek will have 215,450,597 Ordinary Shares in issue and admitted to trading on AIM. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

Enquiries:

Verditek plc 

RH Lord David Willetts FRS (Non-Executive Chairman)         

Dr Geoff Nesbitt (Chief Executive Officer)

Tim Lord (Chief Financial Officer)
Tel: +44 (0)20 7129 1110

[email protected]
WH Ireland Limited (NOMAD and Broker) Tel: +44 (0)20 7220 1666
Chris Hardie (Corporate Finance)

Matthew Chan

Jasper Berry (Corporate Broking)

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ROILRMLTMBITMML

Talk to a Data Expert

Have a question? We'll get back to you promptly.